09 June 2009
Supplements of coenzyme Q10 (CoQ10) may improve the motility and density of sperm in infertile men.
Statistically significant but modest randomized controlled trial results suggest that CoQ10 may have potential clinical applications in infertile men (1). Coenzyme Q1010 supplementation of 300 mg for 26 weeks in infertile men resulted in an improvement in certain semen parameters such as sperm density and motility.
The researcher called for further prospective studies to evaluate if CoQ10 supplementation may play a role in achieving pregnancy in infertile couples.
CoQ10 has properties similar to vitamins, but since it is naturally synthesized in the body it is not classed as such. The coenzyme plays an important role in preserving levels of vitamin E and vitamin C. Sperm quality has been linked to the level of oxidative stress.
There is an ever-growing body of scientific data that shows substantial health benefits of CoQ10 supplementation for people suffering from angina, heart attack and hypertension. Clinical trials have also reported benefits for congestive heart failure.
13 April 2012
A new review says that supplementation with omega-3 fatty acids does not seem to reduce the risk of cardiovascular events and mortality for patients with a history of cardiovascular disease. Experts criticize that the review did not include many studies that showed a preventive effect.
12 October 2011
Unlike other studies, a new US trial claims that daily supplementation with high doses of vitamin E over years may increase the risk of developing prostate cancer.
11 July 2014
A new study from Iran reports that a supplementation with vitamin D and calcium may improve the metabolic profile of pregnant women suffering from gestational diabetes.
